« Back to Record
Citation APA

Goss, P. E., Ingle, J. N., Martino, S., Robert, N. N., Muss, H. B., Piccart-Gebhart, M., Castiglione, M., Tu, D., Shepherd, L., Pritchard, K., Livingston, R., Davidson, N. E., Norton, L., Perez, E. A., Abrams, J. S., Cameron, D. A., Palmer, M. J., Pater, J. L., & National Cancer Institute of Canada Clinical Trials Group MA.17, (2007). Efficacy of letrozole extended adjuvant therapy according to estrogen receptor and progesterone receptor status of the primary tumor: National Cancer Institute of Canada Clinical Trials Group MA.17. Journal of clinical oncology, 25(15), 2006-2011. doi:10.1200/JCO.2006.09.4482


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/55749

Goss, P. E., Ingle, J. N., Martino, S., Robert, N. N., Muss, H. B., Piccart-Gebhart, M., Castiglione, M., Tu, D., Shepherd, L., Pritchard, K., Livingston, R., Davidson, N. E., Norton, L., Perez, E. A., Abrams, J. S., Cameron, D. A., Palmer, M. J., Pater, J. L., & National Cancer Institute of Canada Clinical Trials Group MA.17, (2007). Efficacy of letrozole extended adjuvant therapy according to estrogen receptor and progesterone receptor status of the primary tumor: National Cancer Institute of Canada Clinical Trials Group MA.17. Journal of clinical oncology, 25(15), 2006-2011. doi:10.1200/JCO.2006.09.4482